Transforming growth factor-β1 in bronchoalveolar lavage fluid from children with cystic fibrosis

Pediatric Pulmonology

Volumn 44, Issue 11, 2009, Pages 1057-1064

  Harris, William T ^a   Muhlebach, Marianne S ^b   Oster, Robert A ^c   Knowles, Michael R ^b   Noah, Terry L ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Airway remodeling; Cystic fibrosis lung disease; Inflammation; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BRONCHOSCOPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HOSPITALIZATION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SCHOOL CHILD;

AIRWAY REMODELING; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; MALE; NEUTROPHILS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 72449207576     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21079     Document Type: Article

References (29)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080. (Pubitemid 19231815)
2. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005;6:237-260.
3. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR, Gene Modifier Study. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005;353:1443-1453.
4. Dorfman D, Sandford A, Taylor C, Huang B, Frangolias D, Want Y, Sang R, Pereira L, Sun L, Berthiaume Y, Tsui LC, Paré PD, Durie P, Corey M, Zielenski J. Complex two-gene modulation of lung disease in children with cystic fibrosis. J Clin Invest 2008; 118:1040-1049.
5. Collaco JM, Vanscoy L, Bremer L, McDougal K, Blackman SM, Bowers A, Naughton K, Jennings J, Ellen J, Cutting GR. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 2008;299:417-424. (Pubitemid 351185950)
6. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 2000;55:459-462.
7. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342: 1350-1358. (Pubitemid 30408720)
8. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006;3:413-417. (Pubitemid 44033355)
9. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004;125:754-765. (Pubitemid 38223659)
10. Kwong KY, Niang S, Literat A, Zhu NL, Ramanathan R, Jones CA, Minoo P. Expression of transforming growth factor beta (TGF-b1) by human preterm lung inflammatory cells. Life Sci 2006;79:2349-2356. (Pubitemid 44772931)
11. Bosse Y, Rola-Pleszczynski M. Controversy surrounding the increased expression of TGF-b1 in asthma. Resp Res 2007;8:66.
12. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791.
13. Hilliard TN, Regamy N, Shute JK, Nicholson AG, Alton EW, Bush A, Davies JC. Airway remodelling in children with cystic fibrosis. Thorax 2007;62:1074-1080. (Pubitemid 350206200)
14. Schwarz KB, Rosenweig J, Sharma S, Jones L, Durant M, Potter C, Narkewicz MR. Plasma markers of platelet activation in cystic fibrosis liver and lung disease. J Pediatr Gastroenterol Nutr 2003;37:187-191. (Pubitemid 39274547)
15. Wojnarowski C, Frisker T, Hofbauer E, Grabner C, MosgoellerW, Eichler I, Ziesche R. Cytokine expression in bronchial biopsies of cystic fibrois patients with and without acute exacerbation. Eur Resp J 1999;14:1136-1144.
16. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med 1999;160:186-191.
17. Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol 2006;41:445-451.
18. Miller MB, Gilligan PH. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol 2003;41:4009-4015. (Pubitemid 37099657)
19. Hankinson JL, Odencrantz J, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Resp Care Crit Med 1999;159:179-187. (Pubitemid 29036522)
20. Eigen H, Bieler H, Grant D, Christoph K, Terrill D, Heilman DK, Ambrosius WT, Tepper RS. Spirometric pulmonary function in healthy preschool children. Am J Resp Crit Care Med 2001;163: 619-623. (Pubitemid 32230819)
21. Cystic Fibrosis Foundation. Patient registry 2002 annual data report. Bethesda, Maryland: Cystic Fibrosis Foundation; 2003.
22. Armstong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005;40:500-510. (Pubitemid 41720706)
23. Li MO, Wan YY, Sanjabi S, Roberston AK, Flavell RA. Transforming growth factor beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
24. Chu HW, Trudeau JB, Balzar S,Wenzel SE. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000;106:115-123.
25. COPE: Horst Ibelgaufts' Cytokines & Cells Online Pathfinder Encyclopaedia: www.copewithcytokines.org.
26. Reibman J, Meixler S, Lee TC, Gold LI, Cronstein BN, Haines KA, Kolasinski SL, Weissmann G. Transforming growth factor beta 1, a potent chemoattractant for neutrophils, bypasses classical signal transduction pathways. Proc Natl Acad Sci USA 1991;88:6805-6809.
27. Perkett EA, Ornatowski W, Poschet JF, Deretic V. Chloroquine normalizes aberrant transforming growth factor beta activity in cystic fibrosis bronchial epithelial cells. Pediatr Pulmonol 2006; 41:771-778. (Pubitemid 44157362)
28. Perkett EA. Role of growth factors in lung repair and diseases. Curr Opin Pediatr 1995;7:242-249.
29. Griese M, Potz C, Dietrich P, Westerburg B. Calcium, potassium, urea and total protein are not reliable dilutional markers of bronchoalveolar small volume-lavages in ventilated preterm human neonates. Eur J Med Res 1996;1:565-570.